Several groups have reported that UCA1 is highly expressed in bladder cancer, breast cancer, colorectal cancer, etc. [14, 16, 17], suggesting that UCA1 may serve as a biomarker for the diagnosis of these cancers. Here, UCA1 is linked to colorectal cancer.